Health

The first COVID-19 vaccine to reach phase-1 clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal. According to the study of 108 adults, the vaccine produced neutralising antibodies, and a response mediated by the immune system’s T-cells against the novel coronavirus, SARS-CoV-2. ...

A study of nearly 100,000 coronavirus patients has shown no benefit in treating them with anti-viral drugs hydroxychloroquine and chloroquine and even increased the likelihood of them dying in hospital. Hydroxychloroquine is normally used to treat arthritis but pronouncement from public figures including US President Donald Trump — who announced this week he is taking the drug — has prompted ...

Oxford University and AstraZeneca plan to recruit around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine which on Thursday received US backing worth up to $1.2 billion. The university said on Friday that partner institutions across Britain had started recruiting up to 10,260 adults and children to see how well the human immune system responds ...

Drugs giant AstraZeneca has announced it is ready to provide a potential new coronavirus vaccine from September. The firm said it had concluded deals to deliver at least 400 million doses of the vaccine, which it is developing with Oxford University, BBC reported.AstraZeneca said it was capable of producing one billion doses of the AZD1222 vaccine this year and next. ...

The Ministry of Health and Family Welfare on Tuesday urged the authorities concerned to suspend production, supply, marketing, and sale of all kinds of tobacco products in Bangladesh to help fight against coronavirus. The Health Services Division of the ministry issued a letter to the Industries Ministry in this regard, asking to implement the request and suspend the special permissions ...

The Power, Energy and Mineral Resources Ministry has handed over some 25,000 kits to the Institute of Epidemiology Disease Control and Research (IEDCR) for testing samples to detect novel coronavirus (COVID-19). Senior Scientific Officer of IEDCR Dr Sharmin Sultana received the kits from the ministry on May 17. State Minister for Power, Energy and Mineral Resources Nasrul Hamid said some ...

People walk near the Samaritan’s Purse Emergency Field Hospital in Central Park as the outbreak of the coronavirus disease (COVID-19) continues in the Manhattan borough of New York US, May 8, 2020. When a sprinkling of a reddish rash appeared on Jack McMorrow’s hands in mid-April, his father figured the 14-year-old was overusing hand sanitizer — not a bad thing ...

There is no antidote against coronavirus. That is why it is important to boost one’s resistance against diseases as an effective shield against the virus. Vitamin D is definitely required to increase one’s resistance. The largest source of Vitamin D is sunlight. But due to the lockdown, everyone has to stay indoors. So in order to meet one’s Vitamin D ...

Sorrento Therapeutics believes it has found the first antibody to be used in a cocktail that it’s calling COVI-SHIELD. They say it is so effective it could even be used as a stand-alone therapy. About two months ago, the Sorrento team started analyzing hundreds of antibodies from their library and found about a dozen that blocked the virus that leads ...

When the world scientists are racing against time to develop vaccines, a Chinese firm announced they have built the world’s largest vaccine plant with the annual capacity reaching 100 million doses. The Fourth Construction Co., Ltd. of China Electronics System Engineering made the statement on Monday, claiming a production facility with bio-safety level 3 (BSL-3) is ready to mass produce ...